RI
Regenxbio Inc
🇺🇸XNAS.RGNXUnited StatesHealthcare
$7.98USDup +0.04 (+0.5%)ClosedDelayed12:25 PM
Price$7.98+0.04 (+0.5%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US75901B1070
- CUSIP
- 75901B107
Company
- Employees
- 371
- Headquarters
- Rockville, United States
- Website
- https://www.regenxbio.com
- CEO
- Mr. Curran M. Simpson M.S.
Market
- Shares outstanding
- 66M
- Market cap
- $526.79M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $526.79M
- EPS LTM
- -$2.98calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -2.68calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $174.48M+12%up year on year
- Net income
- -$196.43M-11.88%down year on year
- Gross margin
- 54.22%-32.17%down year on year
- Free cash flow
- -$249.67M-175.25%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.